A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. The research reveals a promising strategy…
New combination therapy inhibits tumor growth and blocks drug-induced resistance in ovarian cancer
